Major technical equipment, including key medical equipment components and raw materials will see their import duties and taxes reduced for eligible importers. Check if your product is eligible with our interactive self-check.
Update 2018-12-27: We have updated our policies database with additional details, scroll down to our self-check app to check your products against this policy.
From the 1st of January 2019, key medical equipment components and raw materials imported into China will be exempt from customs duties and VAT, for those importers that meet certain criteria. This will apply to technical components for major equipment such as MRI, CT/CAT, PET-CT, DR, and others.
This new policy on medical equipment, accessories, and components is in line with the continuous development of China’s domestic equipment manufacturing industry, the import industry, and other supporting industries in recent years.
Earlier this year, import duties on a vast majority of daily consumer goods were reduced, followed by a reduction of import tariffs on common and cancer drugs to 0%. Now, China is looking to the tariffs on large technical equipment, components, and raw material to encourage more global imports.
Together, the Ministry of Finance, the Development and Reform Commission, the Ministry of Industry and Information Technology, the General Administration of China Customs, the State Administration of Taxation, and the Energy Administration jointly issued the upcoming proposal.
Named the “Notice on Adjusting the Catalogue of Import Tax Policies for Major Technical Equipment,” it will cover a broad range of product categories.
The special equipment for medical products list includes 1.5T and above superconducting magnetic resonance systems, 64 rows and above CT, PET-CT, digital mammography, DR, magnetic resonance or CT guided real-time navigation equipment, 6MV and above high-energy medical linear accelerators, as well as hemodialysis machines and other medical equipment use related accessories.
The policy has been developed alongside opinions from industry authorities, industry associations, and enterprise representatives.
Keith Jackson, CEO of Brandon Medical, says, “This is one of a series of significant measures in expanding China’s opening-up. It will support exports enhancing healthcare for China’s ageing 1.4bn population, so opportunities for innovative British technology are huge. With the right expert support, it can be realised. Brandon Medical are working with ACOLINK, making strong progress to access this huge market with our cutting-edge audio-visual solutions.”
As partners with China’s E-commerce Research Centre and member of the China (Henan) Food & Drug Supervision association (which supervises 200+ hospitals and 100+ medical equipment companies in Henan alone), ACOLINK is continually at the forefront of developments in the pharmaceutical and medical trade industry. Zhengzhou, the capital of Henan province and the location of ACOLINK’s main China office and bonded facilities, is currently the only inland pharmaceutical port.
Self-service eligibility check
We have complied the list of commodity categories that are eligible for import tax reductions under this policy. You can check the status against your HS (Harmonized System) category code(s) using the free self-check below.
The policy stipulates certain conditions and restrictions for each commodity group so we can provide further details on a case-by-case basis. If you’d like to find out more, cross-check your list of commodities, or would like to find a Chinese importer, please contact us with your enquiry.
Simply enter the HS code (or part of it, between 4-8 digits) below, click on the “Check” button and follow further instuctions.
Commodity code search against the Import Tax Policy for Major Technical Equipment (2018-11-14)
- Enter the HS commodity code (or part of it, numbers only, between 4-8 digits)
- Press enter, click the "Check" button, or simply wait a short moment
- Follow the instructions in results below
- Reduction of import duties coming into effect 1st July
- Import tariffs on common and cancer drugs reduced to 0%